Duke University Affiliated Physicians, INC.
Duke University Affiliated Physicians, INC. was paid $11.52M by Medicaid between Jan 2018 and Dec 2024, across 30 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.
DURHAM, NC 27705
Next to other Family Medicine Physician providers in North Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,635 | $985K | |
| 2019 | 17,345 | $1.12M | |
| 2020 | 12,129 | $781K | |
| 2021 | 42,052 | $1.70M | |
| 2022 | 68,645 | $2.52M | |
| 2023 | 74,283 | $2.37M | |
| 2024incomplete | 69,650 | $2.04M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 56% | 82,199 | 73,257 | $6.40M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 48,155 | 40,628 | $2.72M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6.4% | 16,864 | 13,735 | $743K |
| 99199 | Unlisted special service, procedure or report | 5.7% | 116,423 | 52,305 | $659K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.1% | 5,752 | 5,140 | $354K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 8,567 | 7,667 | $229K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 4,929 | 4,669 | $123K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 674 | 583 | $77K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 926 | 733 | $76K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,206 | 3,928 | $52K |
| 81003 | <1% | 8,565 | 7,475 | $17K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 122 | 112 | $16K |
18 more codes
| 87634 | <1% | 347 | $9K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 209 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 526 | $7K |
| 81025 | <1% | 1,087 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 416 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 86 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 310 | $4K |
| 87210 | <1% | 991 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,372 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 87 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 29 | $917.94 |
| 87807 | <1% | 63 | $695.74 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 120 | $624.04 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 551 | $520.41 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 57 | $289.91 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 27 | $100.50 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $38.78 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 66 | $2.27 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.